DEL PRETE, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 292
EU - Europa 94
AS - Asia 40
AF - Africa 12
Totale 438
Nazione #
US - Stati Uniti d'America 289
CN - Cina 35
NL - Olanda 22
IT - Italia 21
IE - Irlanda 18
CI - Costa d'Avorio 12
UA - Ucraina 10
FI - Finlandia 8
GB - Regno Unito 4
IN - India 4
SE - Svezia 4
BE - Belgio 3
CA - Canada 3
DE - Germania 2
AT - Austria 1
FR - Francia 1
VN - Vietnam 1
Totale 438
Città #
Chandler 95
Ashburn 28
Amsterdam 22
Beijing 13
Millbury 13
Nanjing 11
Princeton 11
Jacksonville 10
Napoli 8
Boston 5
Des Moines 5
Seattle 5
Pune 4
Wilmington 4
Courcelles 3
Nanchang 3
Naples 3
Ottawa 3
Boardman 2
Dublin 2
Hebei 2
Shenyang 2
Washington 2
Atlanta 1
Changchun 1
Chicago 1
Hanoi 1
Houston 1
Lembach 1
Mcallen 1
Norwalk 1
Norwich 1
Orange 1
Philadelphia 1
Redwood City 1
Tappahannock 1
Tianjin 1
Torino 1
Vienna 1
Woodbridge 1
Zhengzhou 1
Totale 274
Nome #
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. 59
Hepatic arterial embolization in patients with neuroendocrine tumors. 55
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 40
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 39
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study 38
Insulin resistance and acne: a new risk factor for men? 37
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors 36
Limitations of Chromogranin A in clinical practice. 35
Thyroid function in Fabry disease before and after enzyme replacement therapy. 35
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 35
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1 34
Role of Metformin on Recurrence-Free Survival in Neuroendocrine Tumors 19
Totale 462
Categoria #
all - tutte 1.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.618


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 1 1 1
2019/202038 15 0 2 0 2 0 0 0 0 7 8 4
2020/202121 0 2 2 2 2 7 2 0 2 0 2 0
2021/202287 1 0 0 0 0 3 0 0 18 8 29 28
2022/2023172 13 25 3 21 22 22 2 13 23 23 5 0
2023/202480 4 14 5 5 6 13 14 18 0 1 0 0
Totale 462